Table 5 Biological parameter changes from day 0 to day 7 by treatment arms
Treatment Group | Point estimate changes of biological parameters from day 0 to day 7 (95% IC) | Mean difference | p value |
|---|---|---|---|
Haemoglobin (g/dl) | |||
ASAQ | 0.52 ± 0.11 (0.28 – 0.75) | ASAQ ≠ AL: 0.62 | <10-3 |
AL | 1.1 ± 0.09 (0.96 – 1.32) | ASAQ ≠ DHAPQ: 0.62 | <10-3 |
DHAPQ | 1.1 ± 0.08 (0.98 – 1.31) | AL ≠ DHAPQ: 0.001 | 1 |
ALAT (UI/L) | |||
ASAQ | 2.57 ± 1.86 (-1.1 – 6.2) | ASAQ ≠ AL: 1.08 | 1 |
AL | 3.65 ± 1.2 (1.2 – 6.1) | ASAQ ≠ DHAPQ: 0.008 | 1 |
DHAPQ | 2.58 ± 1.5 (-0.3 – 5.5) | AL ≠ DHAPQ: -1.07 | 1 |
ASAT (UI/L) | |||
ASAQ | 6.37 ± 0.4 (5.4 – 7.3) | ASAQ ≠ AL: 3.17 | 0.54 |
AL | 9.55 ± 1.8 (5.9 – 13.1) | ASAQ ≠ DHAPQ: 2.38 | 0.94 |
DHAPQ | 8.75 ± 2.2 (4.3 – 13.2) | AL ≠ DHAPQ: -0.79 | 1 |
Creatinin (6–14 mg/l) | |||
ASAQ | 0.18 ± 0.7 (-1.2 – 1.6) | ASAQ ≠ AL: 1.21 | 0.77 |
AL | 1.39 ± 0.5 (0.3 – 2.4) | ASAQ ≠ DHAPQ: 0.22 | 1 |
DHAPQ | 0.41 ± 0.9 (-1.4 – 2.3) | AL ≠ DHAPQ: -0.98 | 1 |
Bilirubin (0.23 - 1 mg/dl) | |||
ASAQ | 0.17 ± 0.03 (0.1 – 0.23) | ASAQ ≠ AL: 0.74 | <10-3 |
AL | 0.91 ± 0.07 (0.7 – 1.06) | ASAQ ≠ DHAPQ: 0.61 | <10-3 |
DHAPQ | 0.78 ± 0.07 (0.6 – 0.9) | AL ≠ DHAPQ: -0.12 | 0.46 |